In the above article, in Section “3.2. Clinical Outcomes,” the sentence: “Within-group effect sizes for these measures ranged between 0.08 (HADS anxiety, active control group) and 0.63 (SOMS, ASTPP)” needs to be corrected as follows: “Within-group effect sizes for these measures ranged between 0.08 (HADS anxiety, active control group) and 0.52 (PID, ASTPP).”
Abstract: Objective: Depression is common in cancer patients but frequently undetected. Consensus regarding validity and optimal thresholds of screening measures is lacking.
Abstract: Objective: There are no studies investigating the efficacy of short-term psychodynamic psychotherapy in primary fibromyalgia syndrome (FMS). We conducted a randomized controlled trial evaluating an adapted form of individual short-term psychodynamic psychotherapy (ASTPP) versus primary care management (TAU). The study focused on FMS patients with psychiatric comorbidity.Methods: Forty-six female patients with FMS and an International Classification of Diseases, 10th Revision diagnosis of a comorbid depression or anxiety disorder were recruited in a hospital setting